IP Library Granted Patent US 12,667,539
Granted Patent B2
US 12,667,539 · App. 17/955,891 · Granted Jun 30, 2026

Oral gum composition

Inventors: Nicolas H. Von Cosmos (Moravian Falls, NC); Steven Lee Alderman (Lewisville, NC); Michael Zawadzki (Clemmons, NC)
Assignee: Nicoventures Trading Limited
A61K9/0058A61K31/465A61K47/10A61K47/12A61K47/26A61K47/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,539
App. No.
17/955,891
Granted
Jun 30, 2026
Kind
B2
Abstract

The disclosure provides a composition configured for oral use. The composition includes a gum base, one or more bulking agents; an active ingredient having a basic amine functionality; and an organic acid, an alkali metal salt of an organic acid, or a combination thereof, wherein at least a portion the active ingredient having the basic amine functionality is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both.

Claims (71)

1 . An oral composition comprising:

a gum base;

one or more bulking agents;

an active ingredient having a basic amine functionality; and

a combination of an organic acid having a logP value from about 1 to about 12, and an alkali metal salt of an organic acid having a logP value from about 1 to about 12, wherein at least a portion of the active ingredient having the basic amine functionality is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of an ion pair between the basic amine and a conjugate base of the organic acid.

2 . The oral composition of claim 1 , in the form of a chewing gum.

3 . The oral composition of claim 1 , wherein the organic acid has a logP value of from about 1.4 to about 4.5.

4 . The oral composition of claim 1 , wherein the organic acid has a logP value of from about 2.5 to about 3.5.

5 . The oral composition of claim 1 , wherein the organic acid has a logP value of from about 4.5 to about 12, and wherein the composition further comprises a solubility enhancer.

6 . The oral composition of claim 5 , wherein the solubility enhancer is glycerol or propylene glycol.

7 . The oral composition of claim 1 , comprising from about 0.05, about 0.1, about 1, about 1.5, about 2, or about 5, to about 10, about 15, or about 20 molar equivalents of the organic acid, the alkali metal salt thereof, or the combination thereof, relative to the active ingredient having a basic amine functionality, calculated as the amine free base.

8 . The oral composition of claim 1 , comprising from about 2 to about 10 molar equivalents of the organic acid, the alkali metal salt thereof, or the combination thereof, relative to the active ingredient having a basic amine functionality, calculated as the amine free base.

9 . The oral composition of claim 1 , wherein the organic acid comprises benzoic acid, a menthyl or tocopherol monoester of a dicarboxylic acid, or a combination thereof.

10 . The oral composition of claim 9 , wherein the dicarboxylic acid is malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, maleic acid, or a combination thereof.

11 . The oral composition of claim 1 , wherein the organic acid comprises tocopherol succinate, monomenthyl succinate, monomenthyl fumarate, monomenthyl glutarate, or a combination thereof.

12 . The oral composition of claim 11 , further comprising benzoic acid and sodium benzoate.

13 . The oral composition of claim 1 , wherein the organic acid is benzoic acid and the salt thereof is sodium benzoate.

14 . The oral composition of claim 1 , wherein the alkali metal is sodium or potassium.

15 . The oral composition of claim 1 , wherein a ratio of the organic acid to the alkali metal salt of the organic acid is from about 0.1 to about 10.

16 . The oral composition of claim 1 , wherein a pH of the composition is from about 4.0 to about 9.0.

17 . The oral composition of claim 1 , wherein a pH of the composition is from about 4.5 to about 7.

18 . The oral composition of claim 1 , wherein a pH of the composition is from about 5.5 to about 7.

19 . The oral composition of claim 1 , wherein a pH of the composition is from about 4.0 to about 5.5.

20 . The oral composition of claim 1 , wherein a pH of the composition is from about 7.0 to about 9.0.

21 . The oral composition of claim 1 , wherein the active ingredient having a basic amine functionality is nicotine.

22 . The oral composition of claim 21 , wherein the nicotine is present in an amount of from about 0.001 to about 10% by weight of the composition, calculated as the free base and based on the total weight of the composition.

23 . The oral composition of claim 21 , wherein a portion of the nicotine is present as a salt, with the organic acid, as nicotine polacrilex, or a combination thereof.

24 . The oral composition of claim 1 , wherein the gum base comprises a synthetic elastomer.

25 . The oral composition of claim 24 , wherein the gum base further comprises a plasticizer, a filler, a softener, an emulsifier, a wax, an anti-tacking agent, an antioxidant, or a combination thereof.

26 . The oral composition of claim 1 , wherein the bulking agent comprises one or more sugar alcohols.

27 . The oral composition of claim 1 , wherein the oral composition comprises, as the bulking agent, a combination of:

sorbitol in an amount from about 25 to about 50% by weight;

maltitol in an amount from about 10 to about 20% by weight; and

isomalt in an amount from about 10 to about 20% by weight, each based on the total weight of the oral composition.

28 . The oral composition of claim 1 , further comprising one or more additional active ingredients, one or more flavoring agents, one or more salts, one or more sweeteners, one or more humectants, a tobacco material, or combinations thereof.

29 . The oral composition of claim 1 , further comprising one or more additional active ingredients selected from the group consisting of nutraceuticals, botanicals, stimulants, amino acids, vitamins, cannabinoids, cannabimimetics, and terpenes.

30 . The oral composition of claim 1 , comprising:

the gum base in an amount from about 20 to about 30% by weight, based on the total weight of the oral composition;

the bulking agent in an amount from about 50 to about 80% by weight, based on the total weight of the oral composition, wherein the bulking agent comprises one or more sugar alcohols;

a humectant in an amount from about 1 to about 2% by weight, based on the total weight of the oral composition;

nicotine benzoate; and

sodium benzoate.

31 . The oral composition of claim 30 , further comprising nicotine polacrilex.

32 . The oral composition of claim 1 , further comprising flavor granules.

33 . The oral composition of claim 32 , wherein the flavor granules comprise:

a sugar alcohol in an amount by weight from about 60 to about 90%;

a humectant in an amount by weight from about 16 to about 22%;

a sweetener in an amount by weight from about 0.1 to about 0.5%;

a filler in an amount by weight from about 1 to about 3%;

a colorant; and

a flavorant,

wherein each amount by weight is based on the total weight of the flavor granules.

34 . The oral composition of claim 32 , wherein the flavor granules comprise:

a sugar alcohol in an amount by weight from about 15 to about 35%;

a filler in an amount by weight from about 20 to about 50%;

a flavorant in an amount by weight from about 20 to about 30%;

a humectant in an amount by weight from about 15 to about 30%;

a sweetener in an amount by weight from about 0.1 to about 0.5%; and

a colorant in an amount by weight from about 0.1 to about 1.5%,

wherein each amount by weight is based on the total weight of the flavor granules.

35 . The oral composition of claim 34 , wherein the sugar alcohol is isomalt, the filler is microcrystalline cellulose, the humectant is glycerin, and the sweetener is sucralose.

36 . The oral composition of claim 32 , wherein the flavor granules comprise:

a combination of two sugar alcohols in a total amount by weight from about 96 to about 99%;

a sweetener in an amount by weight from about 0.1 to about 0.5%; and a colorant and a flavorant comprising the remainder of the flavor granules.

37 . The oral composition of claim 36 , wherein the flavor granules consist of:

isomalt in an amount by weight from about 92 to about 96%;

maltitol syrup in an amount by weight from about 4 to about 6%;

sucralose in an amount by weight from about 0.1 to about 0.5%; and

the balance consists of colorant and flavorant.

38 . The oral composition of claim 1 , wherein the organic acid and the salt of the organic acid both comprise the same organic acid.

39 . The oral composition of claim 1 , wherein the organic acid and the salt of the organic acid each comprise a different organic acid.

Continuity (3)
Provisional Application 63333729 · Apr 22, 2022
Provisional Application 63250619 · Sep 30, 2021
Related Publication 20230098503A1 · Mar 30, 2023
References Cited (174)
US 5417229A · Summers et al. · 1995 [cited by applicant]
US 6138683A · Hersh et al. · 2000 [cited by applicant]
US 6845777B2 · Pera · 2005 [cited by applicant]
US 6958143B2 · Choi et al. · 2005 [cited by applicant]
US 7032601B2 · Atchley et al. · 2006 [cited by applicant]
US 7056541B1 · Stahl et al. · 2006 [cited by applicant]
US 7507427B2 · Andersen et al. · 2009 [cited by applicant]
US 7810507B2 · Dube et al. · 2010 [cited by applicant]
US 7833555B2 · Andersen et al. · 2010 [cited by applicant]
US 7861728B2 · Holton, Jr. et al. · 2011 [cited by applicant]
US 7900637B2 · Fagerstrom et al. · 2011 [cited by applicant]
US 7950399B2 · Winterson et al. · 2011 [cited by applicant]
US 8069861B2 · Sinclair · 2011 [cited by applicant]
US 8124147B2 · Cheng et al. · 2012 [cited by applicant]
US 8293295B2 · Andersen et al. · 2012 [cited by applicant]
US 8336557B2 · Kumar et al. · 2012 [cited by applicant]
US 8343532B2 · Dam et al. · 2013 [cited by applicant]
US 8424541B2 · Crawford et al. · 2013 [cited by applicant]
US 8469036B2 · Williams et al. · 2013 [cited by applicant]
US 8469037B2 · Liu et al. · 2013 [cited by applicant]
US 8529875B2 · Andersen · 2013 [cited by applicant]
US 8529914B2 · Fuisz et al. · 2013 [cited by applicant]
US 8545870B2 · Dupinay et al. · 2013 [cited by applicant]
US 8591967B2 · Andersen et al. · 2013 [cited by applicant]
US 8613285B2 · Fuisz · 2013 [cited by applicant]
US 8627828B2 · Strickland et al. · 2014 [cited by applicant]
US 8642016B2 · Chau et al. · 2014 [cited by applicant]
US 8714163B2 · Kumar et al. · 2014 [cited by applicant]
US 8741348B2 · Hansson et al. · 2014 [cited by applicant]
US 8747562B2 · Mishra et al. · 2014 [cited by applicant]
US 8828361B2 · Anderson · 2014 [cited by applicant]
US 8833378B2 · Axelsson et al. · 2014 [cited by applicant]
US 8846075B2 · Johnson et al. · 2014 [cited by applicant]
US 8858984B2 · Dam et al. · 2014 [cited by applicant]
US 8863755B2 · Zhuang et al. · 2014 [cited by applicant]
US 8871243B2 · Fankhauser et al. · 2014 [cited by applicant]
US 8931493B2 · Sebastian et al. · 2015 [cited by applicant]
US 8945593B2 · LoCoco et al. · 2015 [cited by applicant]
US 8978661B2 · Atchley et al. · 2015 [cited by applicant]
US 8992974B2 · McCarty · 2015 [cited by applicant]
US 9027567B2 · Gee et al. · 2015 [cited by applicant]
US 9039839B2 · Beeson et al. · 2015 [cited by applicant]
US 9044035B2 · Jackson et al. · 2015 [cited by applicant]
US 9084439B2 · Holton, Jr. · 2015 [cited by applicant]
US 9155321B2 · Cantrell et al. · 2015 [cited by applicant]
US 9161567B2 · Shikata et al. · 2015 [cited by applicant]
US 9161908B2 · Nilsson · 2015 [cited by applicant]
US 9167835B2 · Sengupta et al. · 2015 [cited by applicant]
US 9185931B2 · Gao et al. · 2015 [cited by applicant]
US 9204667B2 · Cantrell et al. · 2015 [cited by applicant]
US 9237768B2 · Carroll et al. · 2016 [cited by applicant]
US 9358296B2 · McCarty · 2016 [cited by applicant]
US 9372033B2 · Lampe et al. · 2016 [cited by applicant]
US 9386800B2 · Sebastian et al. · 2016 [cited by applicant]
US 9402414B2 · Griscik et al. · 2016 [cited by applicant]
US 9402809B2 · Axelsson et al. · 2016 [cited by applicant]
US 9414624B2 · Carroll et al. · 2016 [cited by applicant]
US 9420825B2 · Beeson et al. · 2016 [cited by applicant]
US 9468233B2 · Macko et al. · 2016 [cited by applicant]
US 9474303B2 · Holton, Jr. · 2016 [cited by applicant]
US 9521864B2 · Gao et al. · 2016 [cited by applicant]
US 9565867B2 · Wittorff et al. · 2017 [cited by applicant]
US 9629392B2 · Holton, Jr. · 2017 [cited by applicant]
US 9635881B2 · Sjögren et al. · 2017 [cited by applicant]
US 9675102B2 · Hunt et al. · 2017 [cited by applicant]
US 9763928B2 · Duggins et al. · 2017 [cited by applicant]
US 9775376B2 · Cantrell et al. · 2017 [cited by applicant]
US 9801409B1 · Smith · 2017 [cited by applicant]
US 9848634B2 · Fuisz · 2017 [cited by applicant]
US 9854830B2 · Gao et al. · 2018 [cited by applicant]
US 9884015B2 · Gao et al. · 2018 [cited by applicant]
US 9907748B2 · Borschke et al. · 2018 [cited by applicant]
US 9925145B2 · Hubinette et al. · 2018 [cited by applicant]
US 9930909B2 · Gao et al. · 2018 [cited by applicant]
US 9999243B2 · Gao et al. · 2018 [cited by applicant]
US 10039309B2 · Carroll et al. · 2018 [cited by applicant]
US 10045976B2 · Fusco et al. · 2018 [cited by applicant]
US 10092715B2 · Axelsson et al. · 2018 [cited by applicant]
US 10130120B2 · Mishra et al. · 2018 [cited by applicant]
US 10143230B2 · Mishra et al. · 2018 [cited by applicant]
US 10149850B2 · Mishra et al. · 2018 [cited by applicant]
US 10172810B2 · McCarty · 2019 [cited by applicant]
US 10244786B2 · Gao et al. · 2019 [cited by applicant]
US 10334873B2 · Mishra et al. · 2019 [cited by applicant]
US 10357054B2 · Marshall et al. · 2019 [cited by applicant]
US 10375984B2 · Hernandez Garcia et al. · 2019 [cited by applicant]
US 10390557B2 · Börjesson et al. · 2019 [cited by applicant]
US 10426726B2 · Neergaard · 2019 [cited by applicant]
US 10463070B2 · Carroll et al. · 2019 [cited by applicant]
US 10532046B2 · Rogers et al. · 2020 [cited by applicant]
US 10543205B2 · Wittorff et al. · 2020 [cited by applicant]
US 20040118422A1 · Lundin et al. · 2004 [cited by applicant]
US 20070031539A1 · Calton · 2007 [cited by applicant]
US 20080081071A1 · Sanghvi et al. · 2008 [cited by applicant]
US 20080166395A1 · Roush · 2008 [cited by applicant]
US 20080248089A1 · Bugge · 2008 [cited by examiner]
US 20090023819A1 · Axelsson · 2009 [cited by applicant]
US 20090065013A1 · Essen et al. · 2009 [cited by applicant]
US 20090253754A1 · Selmin et al. · 2009 [cited by applicant]
US 20090301504A1 · Worthen et al. · 2009 [cited by applicant]
US 20100004294A1 · Axelsson et al. · 2010 [cited by applicant]
US 20100061940A1 · Axelsson et al. · 2010 [cited by applicant]
US 20100187143A1 · Essen et al. · 2010 [cited by applicant]
US 20100260690A1 · Kristensen et al. · 2010 [cited by applicant]
US 20100294292A1 · Hodin et al. · 2010 [cited by applicant]
US 20110139164A1 · Mua et al. · 2011 [cited by applicant]
US 20110220130A1 · Mua et al. · 2011 [cited by applicant]
US 20110268809A1 · Brinkley et al. · 2011 [cited by applicant]
US 20120031415A1 · Essen et al. · 2012 [cited by applicant]
US 20120037175A1 · Cantrell et al. · 2012 [cited by applicant]
US 20130078307A1 · Holton, Jr. et al. · 2013 [cited by applicant]
US 20130118512A1 · Jackson et al. · 2013 [cited by applicant]
US 20130152953A1 · Mua · 2013 [cited by examiner]
US 20130177646A1 · Hugerth et al. · 2013 [cited by applicant]
US 20130206150A1 · Duggins et al. · 2013 [cited by applicant]
US 20130251779A1 · Svandal et al. · 2013 [cited by applicant]
US 20130289079A1 · Chen · 2013 [cited by examiner]
US 20130340773A1 · Sebastian et al. · 2013 [cited by applicant]
US 20140130813A1 · Strehle · 2014 [cited by applicant]
US 20140154301A1 · Chau et al. · 2014 [cited by applicant]
US 20140255452A1 · Reddick et al. · 2014 [cited by applicant]
US 20140264992A1 · Miller et al. · 2014 [cited by applicant]
US 20150068544A1 · Moldoveanu et al. · 2015 [cited by applicant]
US 20150068545A1 · Moldoveanu et al. · 2015 [cited by applicant]
US 20150071972A1 · Holton, Jr. et al. · 2015 [cited by applicant]
US 20150096573A1 · Gao et al. · 2015 [cited by applicant]
US 20150096574A1 · Gao et al. · 2015 [cited by applicant]
US 20150096576A1 · Gao et al. · 2015 [cited by applicant]
US 20150296868A1 · Sutton · 2015 [cited by applicant]
US 20160000140A1 · Sebastian et al. · 2016 [cited by applicant]
US 20160073676A1 · Cantrell et al. · 2016 [cited by applicant]
US 20160073689A1 · Sebastian et al. · 2016 [cited by applicant]
US 20160157515A1 · Chapman et al. · 2016 [cited by applicant]
US 20160192703A1 · Sebastian et al. · 2016 [cited by applicant]
US 20170007594A1 · Borschke · 2017 [cited by applicant]
US 20170164651A1 · Mua et al. · 2017 [cited by applicant]
US 20170165252A1 · Mua et al. · 2017 [cited by applicant]
US 20170172995A1 · Repaka et al. · 2017 [cited by applicant]
US 20170280764A1 · Sahlen et al. · 2017 [cited by applicant]
US 20170312261A1 · Changoer et al. · 2017 [cited by applicant]
US 20170318858A1 · Hodin et al. · 2017 [cited by applicant]
US 20180140007A1 · Aspgren et al. · 2018 [cited by applicant]
US 20180140521A1 · Geonnotti et al. · 2018 [cited by applicant]
US 20180140554A1 · Wittorff · 2018 [cited by applicant]
US 20180153211A1 · Persson · 2018 [cited by applicant]
US 20180235273A1 · Carroll et al. · 2018 [cited by applicant]
US 20180255826A1 · Persson et al. · 2018 [cited by applicant]
US 20180257801A1 · Persson · 2018 [cited by applicant]
US 20190037909A1 · Greenbaum et al. · 2019 [cited by applicant]
US 20190134207A1 · Thorsen · 2019 [cited by examiner]
US 20190174812A1 · Nielsen · 2019 [cited by examiner]
US 20190175581A1 · Nielsen et al. · 2019 [cited by applicant]
US 20190255035A1 · Bruun · 2019 [cited by applicant]
US 20200037638A1 · Faraci et al. · 2020 [cited by applicant]
US 20200128870A1 · Hassler et al. · 2020 [cited by applicant]
US 20200138706A1 · Rudraraju et al. · 2020 [cited by applicant]
US 20200275689A1 · Lewerenz · 2020 [cited by applicant]
US 20200297026A1 · Kannisto et al. · 2020 [cited by applicant]
US 20200305496A1 · Gessesse · 2020 [cited by applicant]
US 20200383372A1 · Stahl et al. · 2020 [cited by applicant]
US 20200383373A1 · Stahl et al. · 2020 [cited by applicant]
US 20210068447A1 · Keller · 2021 [cited by examiner]
US 20210386104A1 · Shi · 2021 [cited by examiner]
CN 103005680 · 2013 [cited by applicant]
CN 103263507 · 2013 [cited by applicant]
CN 103494324 · 2014 [cited by applicant]
CN 105192876 · 2015 [cited by applicant]
CN 105595404 · 2016 [cited by applicant]
EP 1474993A1 · 2004 [cited by examiner]
WO WO2008090552A2 · 2008 [cited by examiner]
WO WO2019036243 · 2019 [cited by applicant]
WO WO2021050741A1 · 2021 [cited by examiner]
Li, Qiaoyun, et al. “Investigating the role of ion-pair strategy in regulating nicotine release from patch: Mechanistic insights based on intermolecular interaction and mobility of pressure sensitive adhesive.” European… [cited by examiner]
Robichaud Meagan et al., “Tobacco companies introduce ‘tobacco free’ nicotine pouches”, [cited by applicant]